Marsden P D
Núcleo de Medicina Tropical e Nutrição, Universidade de Brasília, DF, Brasil.
Rev Soc Bras Med Trop. 1994 Apr-Jun;27(2):93-101. doi: 10.1590/s0037-86821994000200007.
Brazilian mucosal leishmaniasis is briefly reviewed, emphasis being given to recent advances clinical management. Patients continue to occupy much hospital bed space and in some cases are notoriously difficult to treat. Indefinite follow up is recommended. Many aspects of the aetiology remain mysterious although Leishmania (Viannia) braziliensis is the most common organism isolated. Perspectives for a more effective treatment, oral and cheap, are still remote.
本文简要回顾了巴西黏膜利什曼病,重点介绍了临床管理方面的最新进展。患者仍占用大量医院床位,在某些情况下治疗难度极大。建议进行长期随访。尽管巴西利什曼原虫(维安尼亚利什曼原虫)是最常见的分离出的病原体,但病因的许多方面仍然不明。更有效、口服且廉价的治疗方法仍遥遥无期。